Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Bone marrow–derived stem cells preserve cone vision in retinitis pigmentosa
Lois E.H. Smith
Lois E.H. Smith
Published September 15, 2004
Citation Information: J Clin Invest. 2004;114(6):755-757. https://doi.org/10.1172/JCI22930.
View: Text | PDF
Commentary

Bone marrow–derived stem cells preserve cone vision in retinitis pigmentosa

  • Text
  • PDF
Abstract

Retinitis pigmentosa is a heritable group of blinding diseases resulting from loss of photoreceptors, primarily rods and secondarily cones, that mediate central vision. Loss of retinal vasculature is a presumed metabolic consequence of photoreceptor degeneration. A new study shows that autologous bone marrow–derived lineage-negative hematopoietic stem cells, which incorporate into the degenerating blood vessels in two murine models of retinitis pigmentosa, rd1 and rd10, prevent cone loss. The use of autologous bone marrow might avoid problems with rejection while preserving central cone vision in a wide variety of genetically disparate retinal degenerative diseases.

Authors

Lois E.H. Smith

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Lin– HSCs preserve cones in retinitis pigmentosa. (A) Cross-section of a...
Lin– HSCs preserve cones in retinitis pigmentosa. (A) Cross-section of a normal human eye showing vascularized retina with avascular area of central vision (macula). Inset shows enlarged detail of retina with two types of photoreceptors; rods mediate night vision and cones mediate color and central fine vision. (B) View through the pupil of a normal eye showing optic nerve, macula, and vascularized retina. (C) View through the pupil of an eye with late-stage retinitis pigmentosa showing pigmentary changes and attenuated vessels, which occur with photoreceptor loss. (D) Engraftment of Lin– HSCs in blood vessels might prevent loss of cones and preserve macular vision as seen in E. However, there will still be loss of rods, giving rise to pigmentary changes.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts